Hybrid assisted limbs starts to affect health care around 2020
Grader A: partial
Grader B: partial
agrees with A, without seeing its verdict
Audit: confirmed
in the fixed audit sample (D11)
Published: partial
Grader A: partial
HAL had 300 suits in 130 Japanese medical and care facilities by 2012, EU medical CE mark in 2013, later Japanese medical approval and FDA clearance (2017). Routine niche use, far below 5% of rehab facilities or patients.
Test: D37 health: share of relevant patients, providers or procedures using it by 2022 (hit >=5%; partial <5% real use by 2022 or 5% in 2023-2025; miss no real use by 2025); relevant: rehabilitation facilities/patients
Grader B: partial
HAL received EU medical certification in 2013, Japanese medical-device approval with insurance coverage for neuromuscular diseases in 2015, and FDA clearance in 2017; it is used in a few hundred facilities. Real routine use, small share of rehab patients.
Test: D37 health: >=5% of relevant rehabilitation patients or facilities use HAL-type suits by 2022 = hit; real use below 5% = partial; none by 2025 = miss.